What are the major opportunities in the Bavencio (Avelumab) market? What are the strategies for the Bavencio (Avelumab) market?

For detailed insights on the major opportunities and strategies in the Bavencio (Avelumab) market, Read More

How does the Bavencio (Avelumab) market relate to the overall economy and other similar markets?

For detailed insights on Bavencio (Avelumab)'s relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Bavencio (Avelumab) market growth? SWOT analysis of the Bavencio (Avelumab) market.

For detailed insights on the key dynamics influencing the Bavencio (Avelumab) market growth and SWOT analysis of the Bavencio (Avelumab) industry, Read More

Global Bavencio (Avelumab) Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Bavencio (Avelumab) Global Market Report 2025

Name: Bavencio (Avelumab) Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Indication (Merkel Cell Carcinoma, Non Small Cell Lung Cancer (NSCLC), Urothelial Carcinoma, Gastric Cancer), By Route of Administration (Intravenous, Subcutaneous), By End User (Hospitals, Clinics, Cancer Research Institutes)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Bavencio (Avelumab) Market?

Bavencio (Avelumab) is a medication used to treat certain types of cancer. It contains the active ingredient avelumab, a type of immunotherapy that works by helping the body's immune system recognize and attack cancer cells.

The main types of indications for bavencio (Avelumab) are merkel cell carcinoma, nonsmall cell lung cancer (nsclc), Urothelial Carcinoma, and Gastric Cancer. Merkel Cell Carcinoma (MCC) is a rare and aggressive form of skin cancer that originates in the Merkel cells, which are located in the outermost layer of the skin (epidermis). These are administered through various routes of administration such as Intravenous, and subcutaneous and are used by various end-users such as hospitals, clinics, and cancer research institutes.

Bavencio (Avelumab) Market Size and growth rate 2025 to 2029: Graph

What Is The Bavencio (Avelumab) Market Size 2025 And Growth Rate?

The bavencio (Avelumab) market size has grown rapidly in recent years. It will grow from $464.01 million in 2024 to $542.30 million in 2025 at a compound annual growth rate (CAGR) of 16.9%. The growth in the historic period can be attributed to increasing demand for immunotherapy treatments, advancements in monoclonal antibody technologies, expanding oncology research funding, growing awareness of innovative cancer therapies, and an emphasis on personalized medicine.

What Is The Bavencio (Avelumab) Market Growth Forecast?

The bavencio (Avelumab) market size is expected to see rapid growth in the next few years. It will grow to $1,002.77 million in 2029 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to increasing adoption of combination immunotherapies, advancements in precision medicine, rising healthcare expenditure, growing focus on biologics in cancer treatment, ongoing clinical trials exploring novel applications, supportive regulatory frameworks, and an aging global population. Major trends in the forecast period include advancements in immune checkpoint inhibitors, rising investment in oncology R&D, expansion into emerging markets, development of next-generation immunotherapies, collaborations for enhanced drug delivery systems, and a focus on cost-effective treatment solutions.

Book your 30 minutes free consultation with our research experts

How Is The Bavencio (Avelumab) Market Segmented?

The bavencio (Avelumab)market covered in this report is segmented –

1) By Indication: Merkel Cell Carcinoma, Non Small Cell Lung Cancer (NSCLC), Urothelial Carcinoma, Gastric Cancer

2) By Route of Administration: Intravenous, Subcutaneous

3) By End User: Hospitals, Clinics, Cancer Research Institutes

What Is Driving The Bavencio (Avelumab) Market? Impact Of Rising Cancer Prevalence On The Growth Of The Bavencio (avelumab) Market

The rising prevalence of cancer is expected to propel the growth of the bavencio (avelumab) market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. The rising prevalence of cancer is due to lifestyle choices such as poor diet and lack of physical activity, increased exposure to environmental pollutants, and advances in diagnostic techniques. Bavencio (avelumab) empowers cancer patients by leveraging its immune checkpoint inhibition mechanism to enhance the body's natural immune response, targeting and destroying cancer cells while offering hope for improved survival and quality of life. For instance, in January 2023, according to the American Cancer Society, a US-based non-profit cancer advocacy organization, the number of cancer cases increased to 1,958,310 in 2023 and 609,820 cancer deaths in the United States. Therefore, the rising prevalence of cancer drives the bavencio (avelumab) market.

Who Are The Major Players In The Global Bavencio (Avelumab) Market?

Major companies operating in the bavencio (avelumab) market include Merck & Co. Inc., Pfizer Inc

What Are The Key Trends Of The Global Bavencio (Avelumab) Market? Strategic Collaborations For Bavencio (Avelumab) Clinical Trials Expanding Cancer Treatment Potential

The key trend in the bavencio (avelumab) market is adopting a strategic partnership approach to enhance technology integration and expand market reach. A strategic partnership typically refers to a collaborative relationship between two or more organizations where they combine their resources, expertise, and efforts to achieve common goals or objectives. For instance, in May 2025, Aulos Bioscience, a US-based immuno-oncology company, partnered with Merck KGaA, a Germany-based science and technology company, for a clinical trial collaboration to study the combination of AU-007, an IL-2 therapeutic, with Bavencio (avelumab) and low-dose aldesleukin. The Phase 2 trial aims to evaluate this combination's potential in treating solid tumors. Bavencio's unique anti-PD-L1 properties, combined with AU-007’s immune-enhancing mechanism, show promise in preclinical trials for eradicating tumors.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Bavencio (Avelumab) Market? Merck KGaA Acquires Exclusive Global Rights to BAVENCIO (Avelumab) from Pfizer to Strengthen Oncology Leadership

In March 2023, Merck KGaA, a Germany-based science and technology company, acquired exclusive worldwide rights to the anti-PD-L1 antibody BAVENCIO (avelumab) from Pfizer Inc. for an undisclosed amount. This decision follows the termination of the alliance agreement and Merck's strategy to enhance its leadership in oncology and reflects its commitment to BAVENCIO, which is recognized as a vital treatment option for various cancers, including metastatic Merkel cell carcinoma and advanced renal cell carcinoma. Pfizer Inc. is a US-based pharmaceutical manufacturing company engaged in manufacturing of BAVENCIO (avelumab).

What Is The Regional Outlook For The Global Bavencio (Avelumab) Market?

North America was the largest region in the bavencio(avelumab) market in 2024. The regions covered in the bavencio (avelumab) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bavencio (avelumab) market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Bavencio (Avelumab) Market?

The bavencio (avelumab) market consists of sales of monotherapy and combination therapy. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Bavencio (Avelumab) Industry?

The bavencio (avelumab)market research report is one of a series of new reports from The Business Research Company that provides bavencio (avelumab)market statistics, including bavencio (avelumab)industry global market size, regional shares, competitors with a bavencio (avelumab)market share, detailed bavencio (avelumab)market segments, market trends, and opportunities, and any further data you may need to thrive in the bavencio (avelumab)industry. This bavencio (avelumab)market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Bavencio (Avelumab) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included !
Revenue Forecast In 2034	Included !
Growth Rate	Included !
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Indication: Merkel Cell Carcinoma, Non Small Cell Lung Cancer (NSCLC), Urothelial Carcinoma, Gastric Cancer 2) By Route of Administration: Intravenous, Subcutaneous 3) By End User: Hospitals, Clinics, Cancer Research Institutes
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Merck & Co. Inc., Pfizer Inc
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Bavencio (Avelumab) Market Characteristics

3. Bavencio (Avelumab) Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Bavencio (Avelumab) Market Trends And Strategies

5. Bavencio (Avelumab) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Bavencio (Avelumab) Growth Analysis And Strategic Analysis Framework

6.1. Global Bavencio (Avelumab) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Bavencio (Avelumab) Market Growth Rate Analysis

6.4. Global Bavencio (Avelumab) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

6.5. Global Bavencio (Avelumab) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

6.6. Global Bavencio (Avelumab) Total Addressable Market (TAM)

7. Global Bavencio (Avelumab) Market Pricing Analysis & Forecasts

8. Bavencio (Avelumab) Market Segmentation

8.1. Global Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Merkel Cell Carcinoma

Non Small Cell Lung Cancer (NSCLC)

Urothelial Carcinoma

Gastric Cancer

8.2. Global Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravenous

Subcutaneous

8.3. Global Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Cancer Research Institutes

9. Global Bavencio (Avelumab) Market Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Bavencio (Avelumab) Market Regional And Country Analysis

10.1. Global Bavencio (Avelumab) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. Global Bavencio (Avelumab) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Bavencio (Avelumab) Market

11.1. Asia-Pacific Bavencio (Avelumab) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Asia-Pacific Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Asia-Pacific Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Bavencio (Avelumab) Market

12.1. China Bavencio (Avelumab) Market Overview

12.2. China Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.3. China Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.4. China Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Bavencio (Avelumab) Market

13.1. India Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. India Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. India Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Bavencio (Avelumab) Market

14.1. Japan Bavencio (Avelumab) Market Overview

14.2. Japan Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. Japan Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. Japan Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Bavencio (Avelumab) Market

15.1. Australia Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.2. Australia Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Australia Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Bavencio (Avelumab) Market

16.1. South Korea Bavencio (Avelumab) Market Overview

16.2. South Korea Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. South Korea Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.4. South Korea Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Bavencio (Avelumab) Market

17.1. Western Europe Bavencio (Avelumab) Market Overview

17.2. Western Europe Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Western Europe Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.4. Western Europe Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Bavencio (Avelumab) Market

18.1. UK Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. UK Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. UK Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Bavencio (Avelumab) Market

19.1. Germany Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Germany Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Germany Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Bavencio (Avelumab) Market

20.1. France Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. France Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. France Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bavencio (Avelumab) Market

21.1. Eastern Europe Bavencio (Avelumab) Market Overview

21.2. Eastern Europe Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Bavencio (Avelumab) Market

22.1. North America Bavencio (Avelumab) Market Overview

22.2. North America Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. North America Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.4. North America Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Bavencio (Avelumab) Market

23.1. USA Bavencio (Avelumab) Market Overview

23.2. USA Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. USA Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. USA Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Bavencio (Avelumab) Market

24.1. Canada Bavencio (Avelumab) Market Overview

24.2. Canada Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. Canada Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. Canada Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Bavencio (Avelumab) Market

25.1. South America Bavencio (Avelumab) Market Overview

25.2. South America Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. South America Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. South America Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Bavencio (Avelumab) Market

26.1. Middle East Bavencio (Avelumab) Market Overview

26.2. Middle East Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. Middle East Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. Middle East Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Bavencio (Avelumab) Market

27.1. Africa Bavencio (Avelumab) Market Overview

27.2. Africa Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Africa Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.4. Africa Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Bavencio (Avelumab) Market Competitive Landscape And Company Profiles

28.1. Bavencio (Avelumab) Market Competitive Landscape

28.2. Bavencio (Avelumab) Market Company Profiles

28.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

28.2.2. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis

29. Global Bavencio (Avelumab) Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Bavencio (Avelumab) Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Bavencio (Avelumab) Market

32. Recent Developments In The Bavencio (Avelumab) Market

33. Bavencio (Avelumab) Market High Potential Countries, Segments and Strategies

33.1 Bavencio (Avelumab) Market In 2029 - Countries Offering Most New Opportunities

33.2 Bavencio (Avelumab) Market In 2029 - Segments Offering Most New Opportunities

33.3 Bavencio (Avelumab) Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Bavencio (Avelumab) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Bavencio (Avelumab) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Asia-Pacific, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Asia-Pacific, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: China, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: China, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: India, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: India, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Japan, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Japan, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Australia, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Australia, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: South Korea, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: South Korea, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: South Korea, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Western Europe, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Western Europe, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Western Europe, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: UK, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: UK, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: UK, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Germany, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Germany, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Germany, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: France, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: France, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: France, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Eastern Europe, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Eastern Europe, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Eastern Europe, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: North America, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: North America, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: North America, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: USA, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: USA, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: USA, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Canada, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Canada, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Canada, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: South America, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: South America, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: South America, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Middle East, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Middle East, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Middle East, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Africa, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Africa, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Africa, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Merck & Co. Inc. Financial Performance

Table 60: Pfizer Inc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Bavencio (Avelumab) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Bavencio (Avelumab) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Asia-Pacific, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Asia-Pacific, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: China, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: China, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: India, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: India, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Japan, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Japan, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Australia, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Australia, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: South Korea, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: South Korea, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: South Korea, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Western Europe, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Western Europe, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Western Europe, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: UK, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: UK, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: UK, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Germany, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Germany, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Germany, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: France, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: France, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: France, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Eastern Europe, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Eastern Europe, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Eastern Europe, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: North America, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: North America, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: North America, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: USA, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: USA, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: USA, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Canada, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Canada, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Canada, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: South America, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: South America, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: South America, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Middle East, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Middle East, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Middle East, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Africa, Bavencio (Avelumab) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Africa, Bavencio (Avelumab) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Africa, Bavencio (Avelumab) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Merck & Co. Inc. Financial Performance

Figure 60: Pfizer Inc Financial Performance

Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Vutrisiran Market Trends: Regional Breakdowns and Strategic Insights

Vyndaqel Outlook 2034: Key Drivers, Trends, and Market Frontiers

Functional Dyspepsia DrugMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Cancer Immunotherapy Global Market Report 2025 – By Product (Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy), By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanom...

Allergy Immunotherapy Global Market Report 2025 – By Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types), By Treatment (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, ...

Drugs for Immunotherapy Global Market Report 2025 – By Type (Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types), By Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, I...

Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2025 – By Drug Type (Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies And Cancer Vaccines, Other Drug Types), By Service Type (Target...

Autoimmune Disease Diagnosis Global Market Report 2025 – By Product (Consumables And Assay Kits, Instruments), By End User (Clinical Laboratories, Hospitals, Others), By Test Type (Routine Laboratory Tests, Autoantibodie...

Immuno-Oncology Drugs Global Market Report 2025 – By Type (Immune Checkpoint Inhibitors, Immune System Modulators, Other Monoclonal Antibodies, Cancer Vaccines, Others), By Therapeutic Application (Melanoma, Lung Cancer,...

Immunosuppressants Global Market Report 2025 – By Drug Class (Corticosteroids, Monoclonal Antibodies (mAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents, Other Drug Classes), By Indication (Organ T...

Frequently Asked Questions

What is the definition of the Bavencio (Avelumab) market?

Bavencio (avelumab) is a medication used to treat certain types of cancer. It contains the active ingredient avelumab, a type of immunotherapy that works by helping the body's immune system recognize and attack cancer cells. For further insights on the Bavencio (Avelumab) market, request a sample here

How will the Bavencio (Avelumab) market drivers and restraints affect the market dynamics? What forces will shape the Bavencio (Avelumab) industry going forward?

The Bavencio (Avelumab) market major growth driver - Impact Of Rising Cancer Prevalence On The Growth Of The Bavencio (avelumab) Market. For further insights on the Bavencio (Avelumab) market, request a sample here

What is the forecast market size or the forecast market value of the Bavencio (Avelumab) market?

The Bavencio (Avelumab) market size has grown strongly in recent years. The bavencio (avelumab) market size has grown rapidly in recent years. It will grow from $464.01 million in 2024 to $542.30 million in 2025 at a compound annual growth rate (CAGR) of 16.9%. The growth in the historic period can be attributed to increasing demand for immunotherapy treatments, advancements in monoclonal antibody technologies, expanding oncology research funding, growing awareness of innovative cancer therapies, and an emphasis on personalized medicine. The bavencio (avelumab) market size is expected to see rapid growth in the next few years. It will grow to $1,002.77 million in 2029 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to increasing adoption of combination immunotherapies, advancements in precision medicine, rising healthcare expenditure, growing focus on biologics in cancer treatment, ongoing clinical trials exploring novel applications, supportive regulatory frameworks, and an aging global population. Major trends in the forecast period include advancements in immune checkpoint inhibitors, rising investment in oncology R&D, expansion into emerging markets, development of next-generation immunotherapies, collaborations for enhanced drug delivery systems, and a focus on cost-effective treatment solutions. For further insights on the Bavencio (Avelumab) market, request a sample here

How is the Bavencio (Avelumab) market segmented?

The bavencio (avelumab)market covered in this report is segmented –
1) By Indication: Merkel Cell Carcinoma; Non Small Cell Lung Cancer (NSCLC); Urothelial Carcinoma; Gastric Cancer
2) By Route of Administration: Intravenous; Subcutaneous
3) By End User: Hospitals; Clinics; Cancer Research Institutes For further insights on the Bavencio (Avelumab) market, request a sample here

Which region has the largest share of the Bavencio (Avelumab) market? What are the other regions covered in the report?

Who are the major players in the Bavencio (Avelumab) market?

Major companies operating in the bavencio (avelumab) market include Merck & Co. Inc., Pfizer Inc . For further insights on the Bavencio (Avelumab) market, request a sample here.

What are the key trends in the Bavencio (Avelumab) market?

Major trends in the Bavencio (Avelumab) market include Strategic Collaborations For Bavencio (Avelumab) Clinical Trials Expanding Cancer Treatment Potential. For further insights on the Bavencio (Avelumab) market, request a sample here.